Ajanta Pharma Limited (AJANTPHARM.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 350.43B |
| Enterprise Value | 351.98B |
| P/E Ratio | 32.88 |
| PEG Ratio | 1.11 |
| Price/Sales Ratio | 6.68 |
| Price/Book Ratio | 8.55 |
| Enterprise/Revenue | 6.69 |
| Enterprise/EBITDA | 23.06 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.2 |
| Operating Margin | 0.38 |
AD
Management Effectiveness
| Return On Assets | 0.2 |
| Return On Equity | 0.28 |
Income Statement
| Revenue | 54.53B |
| Revenue/Share | 497.58 |
| Gross Profit | 28.05B |
| EBITDA | 15.67B |
| Net Income | 10.56B |
| Diluted EPS | 84.53 |
Balance Sheet
| Total Cash | 6.8B |
| Total Cash/Share | 54.43 |
| Total Debt | 1.54B |
| Total Debt/Equity | 0.03 |
| Current Ratio | 2.85 |
| Book Value Per Share | 388.86 |
Price History
| 52-Week Change | 29.44 |
| 52-Week High | 3,796 |
| 52-Week Low | 2,445.8 |
| Moving Average 50 Days | 3,445.11 |
| Moving Average 200 Days | 3,206.25 |
Statistics
| Average Volume | 115,179 |
| Shares Outstanding | 124.96M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 60 |
| Trailing Annual Dividend Yield | 1.81 |
| Payout Ratio | 0 |
| Last Split Factor | 3:2 |
| Last Split Date | June 22, 2022 |
AD
